Biologic Therapy for Psoriasis in Korea: Treatment Guide

Biologic Therapy for Psoriasis in Korea: Treatment Guide

Biologic therapy has changed the treatment landscape for moderate to severe psoriasis. For patients whose psoriasis remains difficult to control with topical medicines, phototherapy, or traditional systemic treatments, biologic medications may provide another targeted treatment option.

South Korea has an established dermatology system for managing chronic plaque psoriasis, including access to multiple classes of biologic medicines. However, starting biologic therapy is not as simple as requesting an injection at a skin clinic. Dermatologists must assess psoriasis severity, previous treatment history, infection risks, other medical conditions, and insurance eligibility.

For international patients living in Busan or traveling to South Korea for medical care, the process can be unfamiliar. Previous medical records, tuberculosis screening, laboratory tests, and documentation of earlier psoriasis treatments may all become important.

This guide explains how biologic therapy for psoriasis works in Korea, who may be considered for treatment, the main biologic classes, screening requirements, costs and insurance considerations, and practical advice for international patients.

What Is Biologic Therapy for Psoriasis?

Biologics are targeted medicines designed to affect specific parts of the immune system involved in psoriasis inflammation.

Psoriasis is an immune-mediated inflammatory disease. Certain signaling proteins, called cytokines, play important roles in the inflammatory pathways that contribute to plaque formation.

Biologic medicines target selected immune pathways rather than broadly treating only the visible surface of the skin.

Depending on the medicine, treatment may target pathways involving:

• Tumor necrosis factor alpha, or TNF-alpha
• Interleukin-12 and interleukin-23
• Interleukin-17
• Interleukin-23

Most psoriasis biologics are administered by injection. The exact injection schedule differs considerably between medications.

Biologic therapy does not permanently cure psoriasis. The goal is long-term disease control, reduction of inflammatory activity, and improvement in skin symptoms and quality of life.

Who Is Biologic Treatment For?

Biologics are primarily considered for patients with moderate to severe psoriasis or clinically significant disease that requires systemic treatment.

A dermatologist may consider factors such as:

• Psoriasis severity
• Body surface area affected
• PASI score
• Quality-of-life impact
• Difficult-to-treat locations
• Nail involvement
• Psoriatic arthritis
• Previous treatment response
• Medical contraindications

PASI stands for Psoriasis Area and Severity Index. It evaluates psoriasis area and features such as plaque thickness, scaling, and inflammatory color changes.

Body surface area, or BSA, estimates how much of the skin is affected.

However, a dermatologist should consider the whole clinical picture. Severe scalp, palm, sole, genital, or nail psoriasis can create substantial problems even when the total affected body surface is relatively limited.

Being medically suitable for a biologic and qualifying for Korean National Health Insurance reimbursement are also separate issues.

How Biologics Work Differently From Traditional Psoriasis Medicines

Traditional systemic psoriasis medications can affect broader biological processes.

Examples include methotrexate and cyclosporine. These medicines remain useful in psoriasis treatment and may be appropriate for many patients.

Biologics are more targeted.

They are designed to block specific inflammatory signals that contribute to psoriasis. This targeted mechanism has allowed dermatologists to achieve high levels of skin improvement in many patients with moderate to severe disease.

However, targeted does not mean risk-free.

Biologic treatment can influence immune function and may require screening for infections before therapy. The potential benefits and risks must be assessed for each patient.

Treatment choice also depends on other medical conditions. A biologic that is appropriate for one person may not be the preferred option for another patient with a different health history.

Main Types of Psoriasis Biologics

Several biologic classes are used for psoriasis.

Understanding the basic categories can help international patients discuss treatment with a Korean dermatologist.

TNF-Alpha Inhibitors

TNF-alpha is an inflammatory signaling protein involved in several immune-mediated diseases.

TNF inhibitors have a long history of use in psoriasis and psoriatic arthritis.

Medicines in this broader treatment class may be used for multiple inflammatory conditions, including certain forms of arthritis and inflammatory bowel disease.

A patient's medical history is important when considering TNF-targeted therapy.

Tuberculosis deserves particular attention. TNF inhibitors have a recognized association with the reactivation of latent tuberculosis, which is one reason infection screening is important before treatment.

IL-12/23 Inhibitors

Interleukin-12 and interleukin-23 are involved in immune signaling.

Biologic treatment targeting the shared pathway of these cytokines has been used for moderate to severe plaque psoriasis.

Injection intervals vary according to the specific medicine and treatment stage.

As with other biologics, a dermatologist will assess infection history and other medical considerations before prescribing treatment.

IL-17 Inhibitors

The IL-17 pathway plays a major role in psoriasis inflammation.

IL-17 inhibitors are targeted biologic medicines used for moderate to severe plaque psoriasis. Some medications within this class are also used for psoriatic arthritis and other inflammatory diseases.

These treatments can produce substantial skin improvement in appropriate patients.

However, medical history matters. Inflammatory bowel disease, infection history, and other clinical factors may influence biologic selection.

Patients should tell their dermatologist about persistent digestive symptoms or a previous diagnosis of Crohn's disease or ulcerative colitis.

IL-23 Inhibitors

IL-23 inhibitors target an inflammatory pathway strongly associated with psoriasis.

This class has become an important part of modern moderate to severe psoriasis treatment.

Some IL-23 biologics have relatively widely spaced maintenance injection schedules compared with treatments that require more frequent administration.

Convenience may be particularly relevant for international patients who travel frequently.

However, injection frequency should not be the only reason for choosing a biologic. Disease characteristics, previous treatment, safety considerations, and access must also be evaluated.

How Effective Are Biologics for Psoriasis?

Modern biologic therapies can achieve major skin improvement in many appropriately selected patients.

Dermatologists often measure treatment response using PASI improvement.

You may hear terms such as:

• PASI 75
• PASI 90
• PASI 100

PASI 75 means a 75% improvement from the patient's baseline PASI score. PASI 90 indicates 90% improvement, while PASI 100 represents complete improvement according to the PASI assessment.

These measures are commonly used in clinical studies and treatment monitoring.

A high PASI response does not mean psoriasis has been permanently cured. Disease control may depend on continuing the prescribed treatment.

Individual response varies. Some patients respond rapidly, while others need more time. A biologic may also lose effectiveness or become unsuitable, making a treatment change necessary.

Biologic Eligibility in South Korea

Clinical suitability for biologic treatment is determined by a dermatologist.

For Korean National Health Insurance reimbursement, formal coverage criteria may apply to specific medicines.

Current Health Insurance Review and Assessment Service reimbursement criteria for several psoriasis biologics include requirements related to chronic severe plaque psoriasis, BSA and PASI severity, and inadequate response or inability to continue specified conventional systemic treatment or phototherapy.

For example, current published criteria for selected biologics include BSA of at least 10% and PASI of at least 10, together with additional prior-treatment requirements.

These rules are administrative reimbursement criteria and can change. They should not be treated as a universal self-assessment tool.

A patient who does not qualify for insurance reimbursement may still require medical treatment. The dermatologist and hospital billing team can explain available options and expected costs.

International patients should confirm current criteria directly with their Korean medical provider.

What Happens Before Starting a Biologic?

A pre-treatment assessment is an important part of biologic therapy.

The dermatologist will usually review:

• Psoriasis history
• Previous treatments
• Current medications
• Infection history
• Vaccination history
• Other chronic diseases
• Pregnancy or pregnancy plans
• Previous biologic use
• Joint symptoms

A physical examination and psoriasis severity assessment may also be performed.

Depending on the planned medicine and individual clinical situation, laboratory testing and infection screening may be required.

Do not hide previous medical conditions because you are concerned that they may prevent biologic treatment. Accurate information helps the doctor select a safer treatment strategy.

Tuberculosis Screening Before Biologic Therapy

Tuberculosis, commonly called TB, is an important consideration before starting biologic treatment.

A person can have latent tuberculosis infection without feeling sick. The bacteria remain inactive, but certain immune-modifying treatments may increase the risk of reactivation.

The risk is particularly established with TNF inhibitors.

Screening may include:

• Medical history
• Tuberculosis exposure history
• Blood testing such as an interferon-gamma release assay
• Chest imaging when clinically appropriate
• Additional assessment if screening is positive

A positive latent TB test does not automatically mean that a patient has contagious active tuberculosis.

Further evaluation is required.

Patients who previously lived in or spent significant time in a country with a higher tuberculosis burden should provide this information. Tell the dermatologist about previous TB treatment or known close contact with a person who had tuberculosis.

Other Tests Before Biologic Treatment

The exact pre-treatment testing plan depends on the biologic and the patient.

Possible assessments may include:

• Complete blood count
• Liver-related blood tests
• Kidney function tests
• Hepatitis screening
• Tuberculosis screening
• Other infection-related testing

Additional tests may be ordered according to medical history.

Patients previously treated overseas should bring recent laboratory results, but they should not assume that every foreign test will replace Korean pre-treatment testing.

The hospital may need updated results or specific documentation before prescribing treatment.

Vaccines and Biologic Therapy

Vaccination history should be discussed before starting biologic treatment.

Certain vaccines may be more appropriately administered before immune-modifying therapy begins. Live vaccines can require particular consideration during biologic treatment.

Do not independently stop a biologic before vaccination.

Instead, tell the dermatologist or vaccination provider exactly which biologic medicine you use and when your most recent dose was administered.

International patients should bring vaccination records when available.

If you are planning international travel, discuss destination-specific vaccination requirements early. Some travel vaccines require additional planning for patients receiving immune-modifying medicines.

How Are Psoriasis Biologics Given?

Most psoriasis biologics are administered by injection.

Depending on the medication, injections may be:

• Given at a hospital or clinic
• Administered using a prefilled syringe
• Delivered through an injection pen
• Self-administered after appropriate training

Many treatments use an initial loading or induction schedule followed by maintenance doses.

The interval between maintenance injections differs by medicine.

Patients should receive clear instructions about:

• Injection timing
• Storage
• Injection technique
• Missed doses
• Travel
• Disposal of injection devices

Never change the injection schedule because your skin looks clear.

Can I Self-Inject a Biologic in Korea?

Some psoriasis biologics are designed for self-injection.

If self-administration is appropriate, a healthcare professional may teach you how to prepare and use the injection device.

Training may include:

1. Checking the medicine.
2. Understanding storage requirements.
3. Choosing an injection site.
4. Cleaning the area.
5. Using the injection device correctly.
6. Disposing of used equipment safely.

Patients who are uncomfortable with self-injection should tell their healthcare team.

Do not rely solely on a social media video to learn injection technique. Devices differ between medicines and manufacturers.

Possible Side Effects and Risks

Biologic medicines can cause side effects.

The specific safety profile depends on the biologic class and individual medicine.

Possible concerns can include:

• Injection-site reactions
• Headache
• Respiratory symptoms
• Infections
• Allergic reactions

Certain biologic classes have additional safety considerations.

Patients should contact their healthcare provider if they develop significant or unusual symptoms.

Seek urgent medical care for severe breathing difficulty, major facial swelling, or other signs of a serious allergic reaction.

Because biologics modify immune pathways, fever or signs of significant infection should not simply be ignored.

What If I Get an Infection?

Tell your treating healthcare provider if you develop a significant infection.

Symptoms that may require medical advice include:

• Persistent fever
• Significant cough
• Shortness of breath
• Painful skin infection
• Unusual weakness
• Symptoms of tuberculosis exposure or illness

Whether a biologic dose should be delayed depends on the medication and clinical situation.

Do not automatically stop treatment for every mild symptom, but do not take the next dose against medical advice when you have been diagnosed with a serious infection.

Contact the prescribing dermatology department for instructions.

How Long Will I Need Biologic Therapy?

Psoriasis is a chronic disease.

Biologic treatment is generally used as ongoing disease control rather than a short course that permanently eliminates psoriasis.

The duration of therapy depends on:

• Treatment effectiveness
• Side effects
• Medical changes
• Patient preference
• Pregnancy planning
• Insurance status
• Development of another illness

Some patients remain on an effective biologic for years.

Others switch because the treatment does not produce an adequate response, gradually loses effectiveness, or causes a safety concern.

Stopping a successful biologic can be followed by psoriasis recurrence.

Any treatment change should be planned with the prescribing dermatologist.

Can You Switch Psoriasis Biologics?

Yes. Switching biologic therapy is possible.

A dermatologist may consider changing treatment when:

• Psoriasis does not improve adequately
• Improvement is lost over time
• Side effects occur
• A new medical condition develops
• Joint disease remains uncontrolled
• Treatment logistics become difficult

The reason for treatment failure can influence the next choice.

Patients should provide accurate information about previous biologics, including treatment duration and response.

If you received treatment outside Korea, bring the exact generic name of the biologic and the date of your last injection.

Biologics and Psoriatic Arthritis

Some psoriasis biologics are also used to manage psoriatic arthritis.

Psoriatic arthritis can cause:

• Joint pain
• Swelling
• Morning stiffness
• Swollen fingers or toes
• Heel pain
• Back symptoms

The presence of joint disease may influence biologic selection.

Tell your Korean dermatologist about musculoskeletal symptoms even if your main concern is skin psoriasis.

A rheumatology consultation may be recommended.

Coordination between dermatology and rheumatology can be particularly important when both skin and joint disease require treatment.

Biologic Therapy Costs in Korea

Biologic medicines can be expensive without insurance coverage.

The total cost of treatment may depend on:

• Specific biologic medicine
• Dose and injection schedule
• Korean National Health Insurance eligibility
• Reimbursement criteria
• Hospital fees
• Laboratory testing
• Follow-up visits

Foreign residents enrolled in South Korea's National Health Insurance may have different coverage circumstances from short-term visitors or medical tourists.

Meeting clinical criteria for biologic therapy does not automatically confirm reimbursement.

Before treatment, ask the hospital to explain:

• Whether the medicine is covered
• Expected patient cost-sharing
• Costs if insurance criteria are not met
• Testing expenses
• Follow-up requirements

Coverage rules can change, so current information should be confirmed directly with the medical provider and relevant Korean insurance system.

Why Consider Psoriasis Care in Busan?

Busan is South Korea's second-largest city and has university hospitals, general hospitals, and dermatology services that manage inflammatory skin diseases.

For residents of southeastern Korea, receiving ongoing psoriasis care in Busan may be more practical than repeatedly traveling to Seoul.

Biologic therapy requires continuity.

Patients may need follow-up appointments, laboratory monitoring, prescription management, and repeated documentation of treatment response.

Choosing a medical provider that is realistically accessible can make long-term care easier.

International patients should confirm whether English-language assistance is available and whether the dermatology department regularly manages moderate to severe psoriasis.

What International Patients Should Bring

International patients should prepare medical documentation before a biologic consultation.

Bring:

• Previous psoriasis records
• Skin biopsy results, if available
• Previous PASI assessments
• Photographs of severe flares
• Medication history
• Phototherapy records
• Biologic treatment history
• Recent laboratory results
• Tuberculosis screening records
• Vaccination information

Generic medication names are especially useful.

If you have used a biologic before, record the exact medicine, dose, injection schedule, reason for stopping, and date of your last dose.

Incomplete treatment history can make it more difficult for a new dermatologist to plan ongoing care.

Common Mistakes to Avoid

One common mistake is assuming biologics are cosmetic injections.

They are prescription systemic therapies that modify specific immune pathways.

Other mistakes include:

• Skipping pre-treatment screening
• Hiding previous infection history
• Changing injection intervals independently
• Stopping treatment as soon as skin clears
• Traveling without planning medication storage
• Forgetting the name of a previous biologic
• Assuming insurance automatically covers treatment
• Ignoring joint symptoms

Good biologic management depends on communication and continuity of care.

Frequently Asked Questions

Are biologics available for psoriasis in South Korea?

Yes. Multiple classes of biologic medicines are used for appropriate psoriasis patients in South Korea. Treatment selection depends on psoriasis severity, medical history, previous therapies, and other clinical factors.

Who qualifies for psoriasis biologic therapy in Korea?

Clinical suitability is determined by a dermatologist. Korean National Health Insurance reimbursement may involve separate severity and prior-treatment criteria, including PASI, body surface area, and treatment history for specific biologics.

Do I need a tuberculosis test before biologic treatment?

Tuberculosis screening is an important part of pre-biologic assessment. The exact evaluation may include a medical history, TB blood testing, and additional investigations when clinically appropriate.

How quickly do psoriasis biologics work?

Response speed varies between biologic medicines and patients. Some people notice improvement relatively early, while full treatment assessment may require additional time. Your dermatologist will evaluate response according to the medicine's expected treatment timeline.

Can biologics permanently cure psoriasis?

No. Biologics can provide substantial disease control, but they are not considered a permanent cure for psoriasis. Symptoms may return if an effective treatment is discontinued.

Can foreigners receive biologic psoriasis treatment in Korea?

Foreign patients can be medically assessed for biologic therapy in South Korea. Insurance coverage, reimbursement eligibility, documentation requirements, and treatment costs depend on individual circumstances.

Can I bring my psoriasis biologic to Korea?

International medication travel requires careful planning. Patients should check Korean medication entry requirements, transport conditions, and manufacturer storage instructions. Bring a prescription or medical letter and keep accurate treatment records.

Can I switch to a different biologic in Korea?

A Korean dermatologist may consider switching biologics when previous treatment is ineffective, loses effectiveness, causes adverse effects, or becomes unsuitable. Bring complete records of your previous biologic therapy.

Is biologic therapy available for psoriasis in Busan?

Yes. Hospital dermatology services in Busan can assess moderate to severe psoriasis and determine whether advanced systemic or biologic therapy is appropriate. Availability of individual medicines and international patient support can vary.

Conclusion

Biologic therapy is an important treatment option for appropriate patients with moderate to severe psoriasis in South Korea. By targeting specific inflammatory pathways such as TNF-alpha, IL-17, or IL-23, these medicines offer a more targeted approach to systemic psoriasis management.

However, biologic treatment requires careful medical assessment. Psoriasis severity, previous therapies, tuberculosis risk, infection history, other medical conditions, and insurance criteria may all influence treatment decisions.

International patients seeking biologic therapy in Busan should bring detailed treatment records, particularly information about previous systemic medicines, phototherapy, biologics, and tuberculosis screening. Patients should also confirm current costs and Korean National Health Insurance coverage rather than assuming advanced treatment is automatically reimbursed.

The best biologic is not simply the newest or most frequently injected medicine. Treatment should be selected according to the individual patient's psoriasis, medical history, safety considerations, and long-term care needs. A dermatologist experienced in medical psoriasis management can help determine whether biologic therapy is appropriate and how treatment should be monitored over time.